U.S. clinicians should consider cholera in patients with acute diarrhea returning from countries with cholera transmission, the Centers for Disease Control and Prevention said in an advisory yesterday, citing eight cases this year in travelers returning to the United States. The advisory includes recommendations to help clinicians, pharmacies and laboratories identify, test and treat suspected cases.

“Although cholera in travelers is rare and sustained community transmission in the United States is unlikely, widespread cholera outbreaks in other countries highlight the need for clinicians in the United States to be prepared to treat travelers with cholera, as they could arrive in the United States at any time,” the advisory notes.

Related News Articles

Headline
Centers for Disease Control and Prevention and state and territorial public health officials Friday met to discuss preparedness planning for bird flu after one…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
AHA is looking forward to spring and March Madness in its latest social media toolkit for hospitals’ and health systems’ use to promote vaccination against the…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
The Centers for Disease Control and Prevention has released a five-part webinar series on its Hospital Sepsis Program Core Elements, which offer guidance to…
Headline
The Home Test to Treat program now offers free testing, telehealth and treatment for both COVID-19 and flu to eligible adults nationwide, the National…